注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Sera Prognostics Inc是一家女性健康診斷公司,專注於利用其蛋白質組學和生物信息學平台發現、開發和商業化具有臨床影響的生物標誌物測試,最初專注於改善妊娠後果。該公司建立了一個蛋白質組學和生物信息學平台,以描述妊娠生物學特徵,並發現和驗證血液中發現的關鍵蛋白質生物標記物,這些標記物是妊娠期間發生的動態變化的準確預測因子。該公司的商業產品,早產兒測試,是一種基於血液的生物標誌物測試,可以準確預測早產的風險,也稱為早產。預胎試驗是一種非侵入性血液試驗,在妊娠第19週或第20週期間,對攜帶單個胎兒的孕婦進行。其生物標誌物妊娠途徑包括先兆子癇、分子生育時間、妊娠糖尿病(GDM)、胎兒生長受限、死產和產後抑鬱症。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Kim Puloma Kamdar | 56 | 2011 | Independent Chairman |
Jane F. Barlow | 62 | 2022 | Independent Director |
Evguenia Lindgardt | 49 | 2021 | President, CEO & Director |
Robert M. Silver | - | - | Member of Scientific Advisory Board |
Robert H. Getzenberg | - | - | Member of Scientific Advisory Board |
Amos E. Madanes | - | - | Member of Scientific Advisory Board |
D. Ware Branch | - | - | Member of Scientific Advisory Board |
C. Matthew Peterson | - | - | Member of Scientific Advisory Board |
Joshua S. Phillips | 57 | 2011 | Independent Director |
David G. Grenache | - | - | Member of Scientific Advisory Board |
Gregory C. Critchfield | 71 | 2011 | Executive Director |
Steven W. Graves | - | 2008 | Co-Founder and Co-Chairman of The Scientific Advisory Board |
Ryan Melroy Trimble | 72 | 2011 | Independent Director |
M. Sean Esplin | - | 2008 | Co-Founder and Co-Chairman of Scientific Advisory Board |
Mansoor Raza Mirza | 63 | 2014 | Independent Director |
Marcus Dean Wilson | 61 | 2021 | Independent Director |
Sandra A. J. Lawrence | 66 | 2021 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核